A Novel highly multiplexed blood-borne pathogen panel (BBPP) shows 95% accuracy, comparable with existing FDA-approved tests, in testing blood for 17 viruses (e.g., HIV-1, HIV-2, Dengue, influenza, Chikungunya) and 13 bacterial (e.g., Escherichia coli, Staphylococcus aureus) and protozoan pathogens (e.g., Leishmania donovani, L. infantum, Babesia microti) simultaneously. Investigators determined that this highly multiplex system is a promising tool for flexible, fast, and accurate blood screening.
A highly multiplexed BBPP using dual-label probe chemistry was developed for simultaneous detection and identification of 17 viral pathogens in human plasma samples and 13 bacterial and protozoan pathogens in human blood samples. This New multiplex PCR-based diagnostic technology aims at faster and accurate pathogen identification. Emerging new pathogens like West Nile Virus, Ebola, Dengue,…
